B. Kolek

发表

Bactericidal mechanism of gatifloxacin compared with other quinolones.

E. Gradelski, D. Bonner, J. Fung-Tomc, 2002, The Journal of antimicrobial chemotherapy.

Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756

L. Valera, L. Aleksunes, E. Gradelski, 2000, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Organisms other than Staphylococci

Hyekyung Yang, E. Gradelski, D. Bonner, 2002, Antimicrobial Agents and Chemotherapy.

In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184

R. Kessler, D. Bonner, J. Fung-Tomc, 1995, Antimicrobial agents and chemotherapy.

Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides

R. Kessler, K. Denbleyker, D. Bonner, 1995, Antimicrobial agents and chemotherapy.

Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2

M. Pucci, R. Kessler, E. Gradelski, 1995, Antimicrobial agents and chemotherapy.

Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.

L. Valera, E. Gradelski, D. Bonner, 2001, International journal of antimicrobial agents.

In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Methicillin-Resistant and -Susceptible Staphylococci

I. Medina, M. Pucci, Junius Clark, 2002, Antimicrobial Agents and Chemotherapy.

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.

D. Bonner, J. Fung-Tomc, E. Huczko, 2000, The Journal of antimicrobial chemotherapy.

Antibacterial activity of BMS-180680, a new catechol-containing monobactam

K. Bush, R. Flamm, E. Gradelski, 1997, Antimicrobial agents and chemotherapy.

Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

D. Bonner, J. Fung-Tomc, B. Kolek, 1993, Antimicrobial Agents and Chemotherapy.

In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria

R. Kessler, J. Fung-Tomc, E. Huczko, 1991, Antimicrobial Agents and Chemotherapy.

Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays

D. Bonner, J. Fung-Tomc, B. Kolek, 1993, Antimicrobial Agents and Chemotherapy.

Intracellular penetration and bactericidal activity of the novel des-fluoro(6) quinolone, BMS-284756.

G. Warr, D. Bonner, J. Fung-Tomc, 2001, The Journal of antimicrobial chemotherapy.

Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.

L. Valera, E. Gradelski, D. Bonner, 2001, International journal of antimicrobial agents.

Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents

L. Valera, E. Gradelski, D. Bonner, 2000, Antimicrobial Agents and Chemotherapy.

Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa

R. Kessler, J. Banville, M. Menard, 1995, Antimicrobial agents and chemotherapy.